Teva Pharmaceuticals will pay $450 million to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal law that prohibits the payment of kickbacks to ...
In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve allegations the company and a related business paid kickbacks to charitable foundations in order ...
The settlement resolved two alleged kickback schemes: Medicare Cost-Sharing Scheme and Copay Assistance Foundations First, Teva has agreed to resolve allegations in a complaint the United States ...
To do that, Teva conducted a "disparagement campaign" against Synthon, the only other company with an authorised drug in Europe containing glatiramer acetate, the Commission said in a statement.
TEVA) has agreed to a $450 million settlement with the U.S. government to resolve allegations that they violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA). The settlement ...
Donald Trump is stoking fears of voter fraud in Pennsylvania, a key battleground state which experts believe could decide the presidential race, after authorities in two counties flagged thousands ...
Combs is currently in jail on allegations of sex trafficking, racketeering and transportation to engage in prostitution Charmaine Patterson is an Associate Editor at PEOPLE. She first began ...
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.
Trump has made multiple allegations of fraud in battleground Pennsylvania. With under a week to go until Election Day, former President Donald Trump and his allies are making multiple allegations ...
INDIANAPOLIS — A former Republican congressional candidate was charged with stealing ballots during a public test of voting machines in Indiana, state police said. Larry Lee Savage Jr., a ...
Teva Pharmaceuticals TEVA-0.81%decrease; red down pointing triangle will pay $450 million to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal ...